<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Milestone Scientific, Inc. — News on 6ix</title>
<link>https://6ix.com/company/milestone-scientific-inc</link>
<description>Latest news and press releases for Milestone Scientific, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/milestone-scientific-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d76b9951cc36e47533c6e2.webp</url>
<title>Milestone Scientific, Inc.</title>
<link>https://6ix.com/company/milestone-scientific-inc</link>
</image>
<item>
<title>Milestone Scientific Inc. Completes $2.15 Million Private Placement</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-inc-completes-dollar215-million-private-placement-1</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-inc-completes-dollar215-million-private-placement-1</guid>
<pubDate>Tue, 21 Apr 2026 12:30:00 GMT</pubDate>
<description>Financing Strengthens Balance Sheet and Supports Commercial Growth Strategy; Backed by Long-Term Investors Including CEO and Chairman of the BoardROSELAND, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of a $2.15 million private placement of common stock and warrants, and an additional $2.69 million if cash warrants ar</description>
</item>
<item>
<title>Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-reports-financial-results-for-fourth-quarter-and-full-year-2025</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-reports-financial-results-for-fourth-quarter-and-full-year-2025</guid>
<pubDate>Tue, 31 Mar 2026 20:15:00 GMT</pubDate>
<description>Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ended December 31, 2025. Eric Hines, Chief Ex</description>
</item>
<item>
<title>Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-schedules-fourth-quarter-and-fy-2025-financial-results-and-business-update-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-schedules-fourth-quarter-and-fy-2025-financial-results-and-business-update-conference-call</guid>
<pubDate>Thu, 26 Mar 2026 13:00:00 GMT</pubDate>
<description>ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2026, to discuss the company’s financial results for the fourth quarter and full year ended December 31, 2025, as well as the company’s corporate progress and other developments. The conference cal</description>
</item>
<item>
<title>Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-launches-compuflor-advisor-program-to-accelerate-commercial-adoption-and-drive-utilization-growth-in-select-mac-jurisdictions-plans-national-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-launches-compuflor-advisor-program-to-accelerate-commercial-adoption-and-drive-utilization-growth-in-select-mac-jurisdictions-plans-national-expansion</guid>
<pubDate>Mon, 23 Feb 2026 13:30:00 GMT</pubDate>
<description>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates. The program, which commen</description>
</item>
<item>
<title>Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-launches-the-wandr-ambassador-program-to-expand-peer-engagement-and-accelerate-market-adoption-in-dentistry</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-launches-the-wandr-ambassador-program-to-expand-peer-engagement-and-accelerate-market-adoption-in-dentistry</guid>
<pubDate>Tue, 06 Jan 2026 13:30:00 GMT</pubDate>
<description>Pilot launched with six registered dental professionals; program expected to scale to 250 ambassadors over 12 monthsROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the launch of The Wand® Ambassador Program, a scalable peer-to-peer engagement initiative designed to expand clinical awareness, education, and adoption of The Wand® STA</description>
</item>
<item>
<title>Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-delivers-stable-revenue-and-reduces-operating-expenses-by-over-dollar500-thousand-in-the-third-quarter-of-2025</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-delivers-stable-revenue-and-reduces-operating-expenses-by-over-dollar500-thousand-in-the-third-quarter-of-2025</guid>
<pubDate>Thu, 13 Nov 2025 21:00:00 GMT</pubDate>
<description>Company outlines continued progress executing operational transformation and growth strategy across its dental and medical segmentsROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced financial results and provided a business update for the third quarter ended September 30, 2025, highlighting continued progress on the Company’s transform</description>
</item>
<item>
<title>Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-schedules-third-quarter-2025-financial-results-and-business-update-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-schedules-third-quarter-2025-financial-results-and-business-update-conference-call</guid>
<pubDate>Thu, 13 Nov 2025 19:15:00 GMT</pubDate>
<description>ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 14th, 2025, to discuss the company’s financial results for the third quarter ended September 30, 2025, as well as the company’s corporate progress and other developments. The conference call will be availab</description>
</item>
<item>
<title>Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-highlights-operational-progress-and-growth-initiatives-under-new-leadership</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-highlights-operational-progress-and-growth-initiatives-under-new-leadership</guid>
<pubDate>Tue, 14 Oct 2025 11:50:00 GMT</pubDate>
<description>Company outlines decisive initiatives to strengthen its dental and medical businesses, reduce operating expenses across the organization, and position Milestone Scientific for accelerated growth and improved financial performanceROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update highlighting the Company’s tran</description>
</item>
<item>
<title>Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-commits-to-regaining-nyse-american-compliance-following-notification</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-commits-to-regaining-nyse-american-compliance-following-notification</guid>
<pubDate>Tue, 14 Oct 2025 11:45:00 GMT</pubDate>
<description>Notification has no immediate effect on the Company’s listing or day-to-day operationsROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has received a letter (the “Letter”) from NYSE American LLC (the “NYSE American”) dated October 8, 2025, stating that the Company is not in compliance with the continued listing stand</description>
</item>
<item>
<title>Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-dr-dawood-sayed-to-board-of-directors-to-advance-commercial-and-clinical-strategy-in-pain-management</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-dr-dawood-sayed-to-board-of-directors-to-advance-commercial-and-clinical-strategy-in-pain-management</guid>
<pubDate>Mon, 22 Sep 2025 13:15:00 GMT</pubDate>
<description>Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain managementROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a nationally recognized leader in interventional pain medicine, to its Board of Directors</description>
</item>
<item>
<title>Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-achieves-25percent-increase-in-revenue-for-the-second-quarter-of-2025</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-achieves-25percent-increase-in-revenue-for-the-second-quarter-of-2025</guid>
<pubDate>Thu, 14 Aug 2025 20:15:00 GMT</pubDate>
<description>Expands senior leadership team and board of directors to support next phase of growthROSELAND, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the second quarter ended June 30, 2025. Neal Goldman, Chairman of the Board, stated, “We are pleased with our revenue performance in the second quart</description>
</item>
<item>
<title>Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-schedules-second-quarter-2025-financial-results-and-business-update-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-schedules-second-quarter-2025-financial-results-and-business-update-conference-call</guid>
<pubDate>Wed, 13 Aug 2025 15:45:00 GMT</pubDate>
<description>ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company’s financial results for the second quarter ended June 30, 2025, as well as the company’s corporate progress and other developments. The conference call will be available via</description>
</item>
<item>
<title>Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-jason-papes-as-senior-vice-president-global-head-of-sales-and-marketing</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-jason-papes-as-senior-vice-president-global-head-of-sales-and-marketing</guid>
<pubDate>Wed, 06 Aug 2025 12:30:00 GMT</pubDate>
<description>Brings over 30 years of experience in scaling commercial operations across healthcare and medical technology sectorsROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Jason Papes as Senior Vice President, Global Head of Sales and Marketing, effective immediately. Mr. Papes brings more than three decades of experience</description>
</item>
<item>
<title>Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-eric-c-hines-as-chief-executive-officer</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-eric-c-hines-as-chief-executive-officer</guid>
<pubDate>Fri, 01 Aug 2025 12:30:00 GMT</pubDate>
<description>Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone’s next phase of commercial executionROSELAND, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Eric C. Hines as Chief Executive Officer, effective immediately. Mr. Hines brings more than 25 years of leadership exp</description>
</item>
<item>
<title>Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-commences-sales-of-compuflor-epidural-system-at-the-painless-center-in-tenafly-new-jersey</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-commences-sales-of-compuflor-epidural-system-at-the-painless-center-in-tenafly-new-jersey</guid>
<pubDate>Thu, 17 Jul 2025 12:30:00 GMT</pubDate>
<description>ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the initiation of commercial sales of its CompuFlo® Epidural System and related disposables at The Painless Center, located in Tenafly, New Jersey. The Painless Center is led by Chi-Shin Jason Chiu, MD, a double board-certified physician in Pain Management and Anesthesiology. A respect</description>
</item>
<item>
<title>Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-highly-accomplished-medtech-executive-shanth-thiyagalingam-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-appoints-highly-accomplished-medtech-executive-shanth-thiyagalingam-to-board-of-directors</guid>
<pubDate>Mon, 19 May 2025 14:00:00 GMT</pubDate>
<description>Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental SegmentsROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Shanth Thiyagalingam, BMedSc, MMKTG, MBA, has joined its Board of Directors, effective May 14, 2025. Mr. Thiyagalingam brings mo</description>
</item>
<item>
<title>Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025</title>
<link>https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-reports-revenue-of-dollar22-million-and-provides-business-update-for-the-first-quarter-of-2025</link>
<guid isPermaLink="true">https://6ix.com/company/milestone-scientific-inc/news/milestone-scientific-reports-revenue-of-dollar22-million-and-provides-business-update-for-the-first-quarter-of-2025</guid>
<pubDate>Thu, 15 May 2025 20:15:00 GMT</pubDate>
<description>Reports Increased CompuFlo® Adoption Following Assignment of Favorable Medicare Payment Rates; Expands Federal Outreach Following FSS Contract AwardROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and reported financial results for the first quarter ended March 31, 2025. Neal Goldman, Chairman and Interim Chief Execut</description>
</item>
</channel>
</rss>